PM Narendra Modi on Friday held a virtual meeting with top officials including those from the centre’s think-tank NITI Aayog on India’s methodology for building up a COVID-19 immunization and making it accessible to the masses.
“Held a meeting to review India’s vaccination strategy and the way forward. Important issues related to progress of vaccine development, regulatory approvals and procurement were discussed,” PM Modi tweeted.
“Reviewed various issues like prioritisation of population groups, reaching out to HCWs, cold-chain Infrastructure augmentation, adding vaccinators and tech platform for vaccine roll-out,” he tweeted.
Held a meeting to audit India’s immunization procedure and the path forward. Significant issues identified with progress of immunization improvement, regulatory approvals and obtainment were examined.
A few drug organizations are associated with building up an antibody to battle COVID-19, which has executed millions across countries since its flare-up in China in December a year ago.
Many are in the advanced stages of preliminaries and they have detailed more than 90% viability.
“Five vaccines are in advanced stages of development in India, out of which 4 are in Phase II/III and one is in Phase-I/II. Countries such as Bangladesh, Myanmar, Qatar, Bhutan, Switzerland, Bahrain, Austria and South Korea – have shown keen interest in partnering for vaccine development of Indian vaccines and use thereof,” the government said in a statement on Friday.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Bengaluru Bytes journalist was involved in the writing and production of this article.